spacer
spacer

PDBsum entry 3db8

Go to PDB code: 
protein ligands links
Transferase PDB id
3db8

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
261 a.a. *
Ligands
1FR
* Residue conservation analysis
PDB id:
3db8
Name: Transferase
Title: Crystal structure of an activated (thr->asp) polo-like kinase 1 (plk1) catalytic domain in complex with compound 041
Structure: Polo-like kinase 1. Chain: a. Fragment: plk1 kinase domain. Engineered: yes. Mutation: yes
Source: Danio rerio. Zebra fish. Organism_taxid: 7955. Gene: plk1. Expressed in: escherichia coli.
Resolution:
3.15Å     R-factor:   0.232     R-free:   0.274
Authors: R.A.Elling,E.J.Hanan,W.Lew,M.J.Romanowski
Key ref: E.J.Hanan et al. (2008). Design and synthesis of 2-amino-isoxazolopyridines as Polo-like kinase inhibitors. Bioorg Med Chem Lett, 18, 5186-5189. PubMed id: 18790636 DOI: 10.1016/j.bmcl.2008.08.091
Date:
30-May-08     Release date:   07-Oct-08    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
Q4KMI8  (Q4KMI8_DANRE) -  Serine/threonine-protein kinase PLK from Danio rerio
Seq:
Struc:
 
Seq:
Struc:
595 a.a.
261 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: E.C.2.7.11.21  - polo kinase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction:
1. L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H+
2. L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H+
L-seryl-[protein]
+ ATP
= O-phospho-L-seryl-[protein]
+ ADP
+ H(+)
L-threonyl-[protein]
+ ATP
= O-phospho-L-threonyl-[protein]
+ ADP
+ H(+)
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    reference    
 
 
DOI no: 10.1016/j.bmcl.2008.08.091 Bioorg Med Chem Lett 18:5186-5189 (2008)
PubMed id: 18790636  
 
 
Design and synthesis of 2-amino-isoxazolopyridines as Polo-like kinase inhibitors.
E.J.Hanan, R.V.Fucini, M.J.Romanowski, R.A.Elling, W.Lew, H.E.Purkey, E.C.VanderPorten, W.Yang.
 
  ABSTRACT  
 
A series of 2-amino-isoxazolopyridines was designed and synthesized as Polo-like kinase (Plk) inhibitors. Key SAR and crystallographic data are discussed. More advanced analogues inhibit Plk1 with good enzymatic activity and modest cell-based activity. Differential selectivity among the three Plk isoforms is observed.
 

 

spacer

spacer